The obesity paradox in community-acquired bacterial pneumonia

Vicente F Corrales-Medina1, Josemon Valayam, Jose A Serpa

  • 1Department of Medicine, Division of Infectious Diseases, University of Ottawa, The Ottawa Hospital, 1053 Carling Ave, CPC 470, Ottawa, Ontario, K1Y 4E9, Canada. vcorrales@uottawa.ca

Insights

Higher body mass index (BMI) may reduce mortality risk in patients with community-acquired bacterial pneumonia. This study found that being overweight or obese was associated with a lower 30-day mortality rate.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Metabolic Disorders

Background:

  • The relationship between obesity and pneumonia outcomes remains unclear.
  • Community-acquired bacterial pneumonia (CABP) poses a significant health burden.
  • Obesity is a prevalent global health issue with complex physiological effects.

Purpose of the Study:

  • To investigate the association between body mass index (BMI) and 30-day mortality in patients with pneumonia.
  • To determine if obesity influences the prognosis of community-acquired bacterial pneumonia.
  • To analyze BMI categories and their correlation with pneumonia-related mortality.

Main Methods:

  • Retrospective analysis of 266 hospitalized patients with confirmed pneumococcal or Haemophilus pneumonia.
  • Patients categorized into underweight, normal weight, overweight, and obese groups based on pre-admission BMI.
  • Statistical analysis to assess the association of BMI with 30-day mortality, adjusting for covariates.

Main Results:

  • Increasing BMI values showed a significant association with reduced 30-day mortality (OR 0.88, CI 0.81-0.96, p<0.01).
  • A significant trend of lower mortality was observed in overweight and obese patient groups (p=0.02).
  • Adjusted analyses confirmed the protective association of higher BMI with pneumonia mortality.

Conclusions:

  • Obesity may confer a protective effect against 30-day mortality in community-acquired bacterial pneumonia.
  • Higher BMI appears to be associated with improved survival outcomes in pneumonia patients.
  • Further research is warranted to elucidate the mechanisms behind this observed protective effect.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.